Angiopoietin-2 and biliary diseases: elevated serum, but not bile levels are associated with cholangiocarcinoma.

by Torsten Voigtländer, Sascha David, Kristina Thamm, Jerome Schlué, Jochen Metzger, Michael P Manns, Tim O Lankisch
Published 2014-01-01

Patients with primary sclerosing cholangitis require more sedation during endoscopic retrograde cholangiography

by Carsten Keil, Lukas Aguirre Dávila, Theodor Framke, Henrike Lenzen, Michael P. Manns, Tim O. Lankisch, Torsten Voigtländer
Published 2017-04-01

MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma.

by Torsten Voigtländer, Shashi K Gupta, Sabrina Thum, Jasmin Fendrich, Michael P Manns, Tim O Lankisch, Thomas Thum
Published 2015-01-01

Gilbert’s syndrome and antiviral therapy of hepatitis C

by Katja Deterding, Kurt Grüngreiff, Tim O. Lankisch, Andrej Potthoff, Matthias J. Bahr, Michael P. Manns, Heiner Wedemeyer, Christian P. Strassburg
Published 2009-07-01

Dilatation Therapy and Demographic Characteristics Significantly Influence the Amount of Propofol for Therapeutic Endoscopic Retrograde Cholangiography

by Christoph A. Schmidt, Carsten Keil, Martha M. Kirstein, Frank Lehner, Michael P. Manns, Thomas von Hahn, Tim O. Lankisch, Torsten Voigtländer
Published 2019-01-01

NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patients

by Christoph Jüngst, Vanessa Stadlbauer, Matthias C. Reichert, Vincent Zimmer, Susanne N. Weber, Lisa Ofner-Ziegenfuß, Torsten Voigtländer, Walter Spindelböck, Peter Fickert, Gabriele I. Kirchner, Frank Lammert, Tim O. Lankisch, Marcin Krawczyk
Published 2017-08-01